跳至主要内容
临床试验/NCT03477955
NCT03477955已完成不适用

PEEK Versus Silicon Interspinous Spacer for Reduction of Supradjacent Segment Degeneration Following Decompression and Short-Segment Instrumentation for Degenerative Lumbar Spinal Stenosis

University Hospital of Patras0 个研究点目标入组 55 人开始时间: 2006年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
55
主要终点
Quality of Life

研究概览

简要总结

A retrospective study that aims to report Adjacent Segment Degeneration (ASD) incidence and spinopelvic balance in short lumbosacral instrumentation for degenerative lumbar spinal stenosis. Although ASD is a common complication following lumbar fusion, the effect of an Interspinous Spacer (IS) in the supradjacent segment in short lumbosacral instrumented fusion and its interaction with spinopelvic balance has not been studied adequately.

详细描述

Methods From 55 consecutive age-, diagnosis- and gender- matched patients aged 60±11 years, 17 (Group R) received PEEK IS; 18 (Group S) received Silicon IS and compared with 20 controls (Group C) without receiving any IS. The functional outcome was evaluated with VAS and ODI. Spinopelvic balance was evaluated using SVA, T12-S1 LL, SS, PT, PI and supradjacent segment disc heights. All spines were preoperatively balanced.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
49 Years 至 71 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Preoperative MRI with degeneration grades<III at the 1st supradjacent lumbar segment.

排除标准

  • •Body mass index≥40kg/m*m
  • •Severe osteoporosis
  • •Lumbar fracture
  • •Preoperative SVA>4cm
  • •Spondylolisthesis grades>II or spondylolytic lesion and acquired spinous process insufficiency in the supradjacent segment cephalad to instrumentation

研究组 & 干预措施

Control Group

Active Comparator

Patients that did not receive PEEK interspinous spacer nor Silicon interspinous spacer

干预措施: PEEK interspinous spacer (Procedure)

Peek Group

Active Comparator

Patients that received PEEK interspinous spacer

干预措施: PEEK interspinous spacer (Procedure)

Silicon Group

Active Comparator

Patients that received Silicon interspinous spacer and did not receive PEEK interspinous spacer

干预措施: PEEK interspinous spacer (Procedure)

结局指标

主要结局

Quality of Life

时间窗: Three years

Oswestry Disability Index scale (0-100)

次要结局

  • Disc heights(Three years)
  • Sacral Slope(Three years)
  • Pain(Three years)

研究者

发起方
University Hospital of Patras
申办方类型
Other
责任方
Principal Investigator
主要研究者

Vasileios Syrimpeis

Orthopaedic Surgeon

University Hospital of Patras

相似试验